| Name | Title | Contact Details |
|---|---|---|
Jeff Caravella |
Chief Financial Officer | Profile |
Agrivida is developing and commercializing solutions that are the next evolutionary step in animal nutrition, using the plant as a factory to produce and deliver highly differentiated products. We are transforming the economics of enzyme and animal feed production through our use of plant-expressed enzymes and plant modification to develop transformational products for monogastric and ruminant animal nutrition.
Altimmune is a clinical-stage immunotherapeutics company focused on the development of products to stimulate robust and durable immune responses for the prevention and treatment of infectious disease.
C4 Therapeutics is pioneering a new class of drugs. C4`s technology platform produces small molecule drugs that harness machinery already present in cells to selectively target disease-relevant proteins for degradation. Our approach has the potential to address a broad range of diseases including cancer, infectious disease, and autoimmune disorders.
Anixa is a publicly-traded biotechnology company developing a number of programs addressing cancer and infectious disease.
Surface Logix, Inc. is a Brighton, MA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.